Patterns of antibody specificity during the BALB/c immune response to hen eggwhite lysozyme - PubMed (original) (raw)
. 1992 Nov 15;149(10):3260-72.
Affiliations
- PMID: 1431104
Patterns of antibody specificity during the BALB/c immune response to hen eggwhite lysozyme
M A Newman et al. J Immunol. 1992.
Abstract
We tested 49 BALB/c antilysozyme mAb from seven intervals during the immune response to lysozyme for patterns of specificity and avidity. We found that the antibody epitopes in composite covered at least 80% of the lysozyme surface, and their patterns of overlap suggest a continuum of potential antibody epitopes. Previously observed regional specificities, which emerged at different times in the immune response, were more discretely defined in late response antibodies, when the majority of mAb could be assigned to one of three functionally nonoverlapping complementation groups. The area covered by each antigenic region may be greater than an individual epitope, and may include multiple epitopes that overlap structurally and functionally to varying degrees. Connectivity between antigenic regions was seen in interactions among early and late stage antibodies, and among secondary stage mAb, but not among tertiary stage mAb from hyperimmunized mice. Patterns of overlap of early and late response antibodies suggest that the organization of antibody specificities change during the progression from primary to secondary to tertiary response. Over the same period in the response, the average relative avidity of IgG1 kappa mAb did not increase, suggesting that "affinity maturation" of serum antibodies reflects an increase in the number and diversity of antibodies, rather than an overall increase in the avidity of individual antibodies.
Similar articles
- Antigenic regions defined by monoclonal antibodies correspond to structural domains of avian lysozyme.
Smith-Gill SJ, Lavoie TB, Mainhart CR. Smith-Gill SJ, et al. J Immunol. 1984 Jul;133(1):384-93. J Immunol. 1984. PMID: 6202787 - Mapping the antigenic epitope for a monoclonal antibody against lysozyme.
Smith-Gill SJ, Wilson AC, Potter M, Prager EM, Feldmann RJ, Mainhart CR. Smith-Gill SJ, et al. J Immunol. 1982 Jan;128(1):314-22. J Immunol. 1982. PMID: 6172484 - Epitopic analysis by anti-I-Ak monoclonal antibodies of I-Ak-restricted presentation of lysozyme peptides.
Rosloniec EF, Gay D, Freed JH. Rosloniec EF, et al. J Immunol. 1989 Jun 15;142(12):4176-83. J Immunol. 1989. PMID: 2470818 - Molecular recognition of lysozyme by monoclonal antibodies.
Smith-Gill SJ. Smith-Gill SJ. EXS. 1996;75:277-300. doi: 10.1007/978-3-0348-9225-4_15. EXS. 1996. PMID: 8765305 Review.
Cited by
- Assessment on Different Vaccine Formulation Parameters in the Protection against Heterologous Challenge with FMDV in Cattle.
Di Giacomo S, Bucafusco D, Schammas JM, Pega J, Miraglia MC, Barrionuevo F, Capozzo AV, Perez-Filgueira DM. Di Giacomo S, et al. Viruses. 2022 Aug 15;14(8):1781. doi: 10.3390/v14081781. Viruses. 2022. PMID: 36016403 Free PMC article. - What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? A Role for Antibody Feedback.
Toellner KM, Sze DM, Zhang Y. Toellner KM, et al. Cold Spring Harb Perspect Biol. 2018 May 1;10(5):a028795. doi: 10.1101/cshperspect.a028795. Cold Spring Harb Perspect Biol. 2018. PMID: 28630078 Free PMC article. Review. - Broad epitope coverage of a human in vitro antibody library.
Sivasubramanian A, Estep P, Lynaugh H, Yu Y, Miles A, Eckman J, Schutz K, Piffath C, Boland N, Niles RH, Durand S, Boland T, Vásquez M, Xu Y, Abdiche Y. Sivasubramanian A, et al. MAbs. 2017 Jan;9(1):29-42. doi: 10.1080/19420862.2016.1246096. Epub 2016 Oct 17. MAbs. 2017. PMID: 27748644 Free PMC article. - Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development.
Schmohl JU, Todhunter D, Oh S, Vallera DA. Schmohl JU, et al. Toxins (Basel). 2015 Oct 10;7(10):4067-82. doi: 10.3390/toxins7104067. Toxins (Basel). 2015. PMID: 26473923 Free PMC article. - Immunopaleontology reveals how affinity enhancement is achieved during affinity maturation of antibodies to influenza virus.
Eisen HN, Chakraborty AK. Eisen HN, et al. Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):7-8. doi: 10.1073/pnas.1219396110. Proc Natl Acad Sci U S A. 2013. PMID: 23284164 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources